New Key Statistics Module, Z-Score and F-Score
OTCPK:ELTP Key Ratios
| Market Cap $ M | 172.31 |
| Enterprise Value $ M | 174.59 |
| P/E(ttm) | 15.39 |
| PE Ratio without NRI | 13.02 |
| Forward PE Ratio | -- |
| Price/Book | 3.39 |
| Price/Sales | 3.63 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | 42.33 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 47.00 |
| EPS (TTM) $ | 0.01 |
| Beneish M-Score | 1.11 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -100.00 |
| EV-to-EBIT | -103.49 |
| EV-to-EBITDA | -538.21 |
| PEG | -- |
| Shares Outstanding M | 1,017.78 |
| Net Margin (%) | 32.87 |
| Operating Margin % | 14.72 |
| Pre-tax Margin (%) | -5.04 |
| Quick Ratio | 1.19 |
| Current Ratio | 1.94 |
| ROA % (ttm) | 27.24 |
| ROE % (ttm) | 43.02 |
| ROIC % (ttm) | -121.75 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.36 |
ELTP Number of Guru Trades
ELTP Volume of Guru Trades
Gurus Latest Trades with OTCPK:ELTP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:ELTP is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Elite Pharmaceuticals Inc Insider Transactions
No Available Data
News about OTCPK:ELTP
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers